Gene · 1806
Papers4,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 4,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Enhanced anticancer activity of novel pyrimidine nucleoside analog in pancreatic cancer. | Am J Cancer Res | 2025 | 40948519 | PubTator, text mining | PubMed |
| A Lack of Complete Linkage Disequilibrium Between c.1236G>A and c.1129-5923C>G HapB3 Variants of DPYD: A Call to Revise European Pharmacogenetic Guidelines. | Int J Mol Sci | 2025 | 40943060 | PubTator, text mining | PubMed |
| Phenotyping and genotyping for the dihydropyrimidine dehydrogenase test in Italy: a precise diagnostic strategy to detect rare variants and improve drug administration. | Clin Biochem | 2025 | 40939752 | PubTator, text mining | PubMed |
| Polypharmacy driven synergistic toxicities in elderly breast cancer chemotherapy drug management and adverse drug reactions: a mini review. | Front Pharmacol | 2025 | 40932868 | PubTator, text mining | PubMed |
| SuperGLUE facilitates an explainable training framework for multi-modal data analysis. | Cell Rep Methods | 2025 | 40914154 | PubTator, text mining | PubMed |
| Clinical implementation and outcome evaluation of dihydropyrimidine dehydrogenase (DPYD) pharmacogenomic testing for fluoropyrimidine dosing in a Canadian Provincial Healthcare center. | Clin Biochem | 2025 | 40912527 | PubTator, text mining | PubMed |
| Suspected capecitabine-induced fatal toxicity in the context of a new DPYD variant. | BMJ Case Rep | 2025 | 40887140 | PubTator, text mining | PubMed |
| Trifluridine- and tipiracil-induced DPD inhibition mimicking DPD deficiency: a case report. | Front Oncol | 2025 | 40874219 | PubTator, text mining | PubMed |
| Author Correction: P53 represses pyrimidine catabolic gene dihydropyrimidine dehydrogenase (DPYD) expression in response to thymidylate synthase (TS) targeting. | Sci Rep | 2025 | 40858655 | PubTator, text mining | PubMed |
| A thymine-challenge test to prospectively evaluate dihydropyrimidine dehydrogenase activity for risk of severe 5-fluorouracil-induced gastrointestinal toxicity. | Cancer Chemother Pharmacol | 2025 | 40824448 | PubTator, text mining | PubMed |
| Opportunistic analysis of clinically actionable DPYD gene variants in a germline testing cohort in India. | Pharmacogenomics | 2025 | 40810747 | PubTator, text mining | PubMed |
| Optimization and Evaluation of Complementary Degrader Discovery Assays for Application in Screening. | ACS Pharmacol Transl Sci | 2025 | 40810141 | PubTator, text mining | PubMed |
| A roadmap for personalized medicine: the findings of the IC2PerMed project. | Front Med (Lausanne) | 2025 | 40809424 | PubTator, text mining | PubMed |
| Shape transitions of red blood cell under oscillatory flows in microchannels. | AIP Adv | 2025 | 40808772 | PubTator, text mining | PubMed |
| Genetic variants and clinical determinants affecting the response to 5-Fluorouracil-based treatment in Chilean patients with advanced colorectal cancer. | Front Oncol | 2025 | 40786508 | PubTator, text mining | PubMed |
| Pharmacogenetic exploration of buprenorphine and related metabolites in umbilical cord blood. | Toxicol Rep | 2025 | 40761746 | PubTator, text mining | PubMed |
| Molecular landscape of non-driver genes in myeloproliferative neoplasms through 333 cancer genes panel: Insights to reveal in Pakistan. | BMC Med Genomics | 2025 | 40760728 | PubTator, text mining | PubMed |
| The history and future of pharmacogenetics in Aotearoa/New Zealand. | J R Soc N Z | 2025 | 40756875 | PubTator, text mining | PubMed |
| Personalizing cancer therapy: the role of pharmacogenetics in overcoming drug resistance and toxicity. | Mol Biol Rep | 2025 | 40751817 | PubTator, text mining | PubMed |
| Efficacy and Safety of a 3-Weekly TS-1 Adjuvant Regimen in Advanced Gastric Cancer: A Pilot Study. | Cancer Med | 2025 | 40741776 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1806/papers?page=7